Analyst Viewpoint
Increase in awareness about sex education and reproductive wellness is a primary factor contributing to the hormonal contraceptive market growth.
Rise in family planning decisions, especially in the urban landscape, is also augmenting market trajectory.
Surge in the number of e-commerce platforms is another factor bolstering the hormonal contraceptive industry size. Online platforms offer easy access to contraceptives and other sexual wellness products, thus helping tackle societal stigma while ensuring safety and overall emotional wellbeing for women.
Prominent players in the global hormonal contraceptive market are investing substantially in advancements in low-dosage alternatives and innovative hormone release and delivery mechanisms to better cater to evolving consumer preferences.
Hormonal contraceptives are specialized drugs that consist of synthetic hormones such as estrogen and progestin that prevent pregnancy.Hormone-based contraceptives are available in several forms including oral pills, patches, injections, and vaginal rings.
Recent hormonal contraceptive market trends indicate an enhanced focus on women’s safety, emotional health, and reduced side effects.Pharmaceutical firms are experimenting with lower hormone dosages such as ultra-low dose oral pills and intrauterine devices (IUDs) with localized hormone delivery mechanisms.
Additionally, innovations in hormone release and delivery mechanisms with products such as vaginal rings and digital health solutions are gaining traction to make reproductive health more effective and accessible.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Awareness about sex education and reproductive wellness is essential for good decision-making during family planning.
Governments, education boards, and NGOs play a collaborative and crucial role in educating the youth and the general public by offering accessible resources and conducting workshops and awareness campaigns to foster positive attitude around sexuality, reproductive health, and relationships.
The Government of India’s Ministry of Health and Family Welfare allocated about INR 342.5 Cr (US$ 42.0 Mn) for family planning and reproductive health wellness awareness campaigns in 2021.
The Government of Canada has a decade-long commitment to fund US$ 1.4 Bn annually for public initiatives around women and children's health. Around US$ 700.0 Mn of this funding is targeted toward sexual and reproductive health and rights.
Empowered individuals who make conscious choices based on accurate information are literate about contraceptives and have a high chance of adopting hormonal contraceptives, thus advancing the hormonal contraceptives market demand.
In recent times, there has been a surge in online shopping platforms or e-commerce websites or apps due to the rising inclination toward convenience and comfort-based purchasing among modern consumers.
E-commerce platforms offer a discreet and easy way for individuals to search, choose, and buy a variety of products, including hormonal contraceptives such as injectables, oral pills, and patches.
They also assist in navigating the stigma around sexuality. Awareness and accessibility to steroidal contraceptives and birth control is likely to increase, as more hormonal drugs get approval to be bought over-the-counter. This is projected to foster hormonal contraceptive market expansion.
According to a survey conducted by KKF, a health policy advocacy group, most young people buy contraceptives online owing to the ease of access and mitigation of the risk of stigma. Most people who buy contraceptives online are in the age group of 18-25 (32%) and 26-35 (46%).
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America held the largest hormonal contraceptive market share in 2022. Rise in awareness around sexual wellness and reproductive health, and the presence of robust healthcare infrastructure are augmenting the market growth of the region.
According to a report by the Centers for Disease Control and Prevention (CDC), in 2020, 620,327 legal abortions occurred across 47 states of the U.S. The report also states that nearly 45% of the teenage population in the U.S. is sexually active and in need of contraceptives.
The hormonal contraceptive industry in Europe is projected to grow at a steady pace from 2023 to 2031. Progressive government initiatives and access to public healthcare are some of the factors propelling hormonal contraceptive market dynamics of the region.
Prominent manufacturers operating in the hormonal contraceptive market are investing in the development of birth control patches and reproductive hormone inhibitors to cater to a consumer base that is highly aware of their reproductive health.
Constant product innovation via collaborations with other players and mergers & acquisitions are key strategies employed by the leading players in the global hormonal contraceptive landscape.
AbbVie, Inc., Afaxys, Inc., Bayer AG, Agile Therapeutics, Merck & Co., Inc., Piramal Enterprises Ltd., Pfizer Inc., HLL Lifecare Limited are the prominent companies operating in the worldwide market.
The hormonal contraceptive market report highlights parameters such as business strategies, company overview, product portfolio, financial overview, and business segments of these companies.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 21.8 Bn |
| Market Forecast Value in 2031 | US$ 33.8 Bn |
| Growth Rate (CAGR) | 5.0% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 21.8 Bn in 2022
It is projected to grow at a CAGR of 5.0% from 2023 to 2031
Rise in awareness about sex education and reproductive health, and expansion in e-commerce sector
North America dominated the global landscape in 2022
AbbVie, Inc., Afaxys, Inc., Bayer AG, Agile Therapeutics, Merck & Co., Inc., Piramal Enterprises Ltd., Pfizer Inc., HLL Lifecare
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Hormonal Contraceptive Market
4. Market Overview
4.1. Introduction
4.1.1. Technology Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Hormonal Contraceptive Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Technology/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Hormonal Contraceptive Market Analysis and Forecast, by Method
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Method, 2017–2031
6.3.1. Oral Contraceptives
6.3.2. Transdermal Patches
6.3.3. Injectable Contraceptives
6.3.4. Intrauterine Contraceptives
6.3.5. Vaginal Rings
6.4. Market Attractiveness Analysis, by Method
7. Hormonal Contraceptive Market Analysis and Forecast, by Hormones
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Hormones, 2017–2031
7.3.1. Progestin Only
7.3.2. Combined Hormones
7.4. Market Attractiveness Analysis, by Hormones
8. Hormonal Contraceptive Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2017–2031
8.3.1. Drug Stores
8.3.2. Gynecology/Fertility Clinics
8.3.3. E-commerce
8.3.4. Others
8.4. Market Attractiveness Analysis, by Hormones
9. Hormonal Contraceptive Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Hormonal Contraceptive Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Method, 2017–2031
10.3.1. Oral Contraceptives
10.3.2. Transdermal Patches
10.3.3. Injectable Contraceptives
10.3.4. Intrauterine Contraceptives
10.3.5. Vaginal Rings
10.4. Market Value Forecast, by Hormones, 2017–2031
10.4.1. Progestin Only
10.4.2. Combined Hormones
10.5. Market Value Forecast, by Distribution Channel, 2017–2031
10.5.1. Drug Stores
10.5.2. Gynecology/Fertility Clinics
10.5.3. E-commerce
10.5.4. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Method
10.7.2. By Hormones
10.7.3. By Distribution Channel
10.7.4. By Country
11. Europe Hormonal Contraceptive Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Method, 2017–2031
11.3.1. Oral Contraceptives
11.3.2. Transdermal Patches
11.3.3. Injectable Contraceptives
11.3.4. Intrauterine Contraceptives
11.3.5. Vaginal Rings
11.4. Market Value Forecast, by Hormones, 2017–2031
11.4.1. Progestin Only
11.4.2. Combined Hormones
11.5. Market Value Forecast, by Distribution Channel, 2017–2031
11.5.1. Drug Stores
11.5.2. Gynecology/Fertility Clinics
11.5.3. E-commerce
11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Method
11.7.2. By Hormones
11.7.3. By Distribution Channel
11.7.4. By Country/Sub-region
12. Asia Pacific Hormonal Contraceptive Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Method, 2017–2031
12.3.1. Oral Contraceptives
12.3.2. Transdermal Patches
12.3.3. Injectable Contraceptives
12.3.4. Intrauterine Contraceptives
12.3.5. Vaginal Rings
12.4. Market Value Forecast, by Hormones, 2017–2031
12.4.1. Progestin Only
12.4.2. Combined Hormones
12.5. Market Value Forecast, by Distribution Channel, 2017–2031
12.5.1. Drug Stores
12.5.2. Gynecology/Fertility Clinics
12.5.3. E-commerce
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Method,
12.7.2. By Hormones
12.7.3. By Distribution Channel
12.7.4. By Country/Sub-region
13. Latin America Hormonal Contraceptive Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Method, 2017–2031
13.3.1. Oral Contraceptives
13.3.2. Transdermal Patches
13.3.3. Injectable Contraceptives
13.3.4. Intrauterine Contraceptives
13.3.5. Vaginal Rings
13.4. Market Value Forecast, by Hormones, 2017–2031
13.4.1. Progestin Only
13.4.2. Combined Hormones
13.5. Market Value Forecast, by Distribution Channel, 2017–2031
13.5.1. Drug Stores
13.5.2. Gynecology/Fertility Clinics
13.5.3. E-commerce
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Method,
13.7.2. By Hormones
13.7.3. By Distribution Channel
13.7.4. By Country/Sub-region
14. Middle East & Africa Hormonal Contraceptive Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Method, 2017–2031
14.3.1. Oral Contraceptives
14.3.2. Transdermal Patches
14.3.3. Injectable Contraceptives
14.3.4. Intrauterine Contraceptives
14.3.5. Vaginal Rings
14.4. Market Value Forecast, by Hormones, 2017–2031
14.4.1. Progestin Only
14.4.2. Combined Hormones
14.5. Market Value Forecast, by Distribution Channel, 2017–2031
14.5.1. Drug Stores
14.5.2. Gynecology/Fertility Clinics
14.5.3. E-commerce
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Method,
14.7.2. By Hormones
14.7.3. By Distribution Channel
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. AbbVie, Inc.
15.3.1.1. Company Overview
15.3.1.2. Technology, Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Afaxys, Inc.
15.3.2.1. Company Overview
15.3.2.2. Technology, Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Bayer AG
15.3.3.1. Company Overview
15.3.3.2. Technology, Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Agile Therapeutics
15.3.4.1. Company Overview
15.3.4.2. Technology, Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Merck & Co., Inc.
15.3.5.1. Company Overview
15.3.5.2. Technology, Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Piramal Enterprises Ltd.
15.3.6.1. Company Overview
15.3.6.2. Technology, Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Pfizer Inc.
15.3.7.1. Company Overview
15.3.7.2. Technology, Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. HLL Lifecare Limited
15.3.8.1. Company Overview
15.3.8.2. Technology, Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
List of Tables
Table 01: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017–2031
Table 02: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017–2031
Table 03: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 04: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017–2031
Table 07: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017–2031
Table 08: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 09: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017–2031
Table 11: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017–2031
Table 12: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 13: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017–2031
Table 15: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017–2031
Table 16: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 17: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017–2031
Table 19: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017–2031
Table 20: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 21: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017–2031
Table 23: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017–2031
Table 24: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
List of Figures
Figure 01: Hormonal Contraceptive Market Size (US$ Mn) and Distribution (%), by Region, 2017–2031
Figure 02: Hormonal Contraceptive Market Revenue (US$ Mn), by Method, 2022
Figure 03: Hormonal Contraceptive Market Value Share, by Method, 2022
Figure 04: Hormonal Contraceptive Market Revenue (US$ Mn), by Hormones, 2022
Figure 05: Hormonal Contraceptive Market Value Share, by Hormones, 2022
Figure 06: Hormonal Contraceptive Market Revenue (US$ Mn), by Distribution Channel, 2022
Figure 07: Hormonal Contraceptive Market Value Share, by Distribution Channel, 2022
Figure 08: Hormonal Contraceptive Market Value Share, by Region, 2022
Figure 09: Hormonal Contraceptive Market Value (US$ Mn) Forecast, 2017–2031
Figure 10: Hormonal Contraceptive Market Value Share Analysis, by Method, 2017–2031
Figure 11: Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017–2031
Figure 12: Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017–2031
Figure 13: Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017–2031
Figure 14: Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017–2031
Figure 15: Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017–2031
Figure 16: Hormonal Contraceptive Market Value Share Analysis, by Region, 2017–2031
Figure 17: Hormonal Contraceptive Market Attractiveness Analysis, by Region, 2017–2031
Figure 18: North America Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Hormonal Contraceptive Market Attractiveness Analysis, by Country, 2017–2031
Figure 20: North America Hormonal Contraceptive Market Value Share Analysis, by Country, 2017–2031
Figure 21: North America Hormonal Contraceptive Market Value Share Analysis, by Method, 2017–2031
Figure 22: North America Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017–2031
Figure 23: North America Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017–2031
Figure 24: North America Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017–2031
Figure 25: North America Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017–2031
Figure 26:North America Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017–2031
Figure 27: Europe Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 29: Europe Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017–2031
Figure 30: Europe Hormonal Contraceptive Market Value Share Analysis, by Method, 2017–2031
Figure 31: Europe Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017–2031
Figure 32: Europe Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017–2031
Figure 33: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017–2031
Figure 34: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017–2031
Figure 35: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017–2031
Figure 36: Asia Pacific Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 38: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017–2031
Figure 39: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Method, 2017–2031
Figure 40: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017–2031
Figure 41: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017–2031
Figure 42: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017–2031
Figure 43: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017–2031
Figure 44: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017–2031
Figure 45: Latin America Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 47: Latin America Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017–2031
Figure 48: Latin America Hormonal Contraceptive Market Value Share Analysis, by Method, 2017–2031
Figure 49: Latin America Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017–2031
Figure 50: Latin America Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017–2031
Figure 51: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017–2031
Figure 52: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017–2031
Figure 53: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017–2031
Figure 54: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 56: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017–2031
Figure 57: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Method, 2017–2031
Figure 58: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017–2031
Figure 59: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017–2031
Figure 60: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017–2031
Figure 61: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017–2031
Figure 62: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Hormonal Contraceptive Market
*86 figures and 60 tables includes